Device VCs not Immune to Crisis

The difficulties on Wall Street are washing down to the private market causing medical device VCs to reconsider investment strategies and exiting routes.

Tom Salemi

Conventional wisdom has always suggested that the public markets have little or no immediate impact on how venture investors operate. After all, venture capital investors—particularly those investing in the life...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Scrip